The use of mycophenolate mofetil in treating patients with non responding aplastic anemia

G. G. Gan, Leong Chooi Fun, J. V. Sangkar, A. Teh, K. Y. Goh, S. K. Cheong

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for graft versus host disease in haemtopoeitic stem cell transplantation. It is thought that mycophenolate mofetil may be useful in this groups of patients. In this short report, mycophenolate mofetil was tried in 6 patients who had severe aplastic anemia with variable doses for a minimum duration of 9 months. The result has however not been encouraging.

Original languageEnglish
Pages (from-to)311-313
Number of pages3
JournalMedical Journal of Malaysia
Volume60
Issue number3
Publication statusPublished - 2005

Fingerprint

Mycophenolic Acid
Aplastic Anemia
Stem Cell Transplantation
Immunosuppressive Agents
Graft Rejection
Graft vs Host Disease
Disease Management
Pharmaceutical Preparations
Transplants
Therapeutics

Keywords

  • Aplastic anemia
  • Immunosuppressive
  • Mycophenolate mofetil

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gan, G. G., Chooi Fun, L., Sangkar, J. V., Teh, A., Goh, K. Y., & Cheong, S. K. (2005). The use of mycophenolate mofetil in treating patients with non responding aplastic anemia. Medical Journal of Malaysia, 60(3), 311-313.

The use of mycophenolate mofetil in treating patients with non responding aplastic anemia. / Gan, G. G.; Chooi Fun, Leong; Sangkar, J. V.; Teh, A.; Goh, K. Y.; Cheong, S. K.

In: Medical Journal of Malaysia, Vol. 60, No. 3, 2005, p. 311-313.

Research output: Contribution to journalArticle

Gan, GG, Chooi Fun, L, Sangkar, JV, Teh, A, Goh, KY & Cheong, SK 2005, 'The use of mycophenolate mofetil in treating patients with non responding aplastic anemia', Medical Journal of Malaysia, vol. 60, no. 3, pp. 311-313.
Gan, G. G. ; Chooi Fun, Leong ; Sangkar, J. V. ; Teh, A. ; Goh, K. Y. ; Cheong, S. K. / The use of mycophenolate mofetil in treating patients with non responding aplastic anemia. In: Medical Journal of Malaysia. 2005 ; Vol. 60, No. 3. pp. 311-313.
@article{d54a6b32cd2f4b76b875fbeb9438744c,
title = "The use of mycophenolate mofetil in treating patients with non responding aplastic anemia",
abstract = "Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for graft versus host disease in haemtopoeitic stem cell transplantation. It is thought that mycophenolate mofetil may be useful in this groups of patients. In this short report, mycophenolate mofetil was tried in 6 patients who had severe aplastic anemia with variable doses for a minimum duration of 9 months. The result has however not been encouraging.",
keywords = "Aplastic anemia, Immunosuppressive, Mycophenolate mofetil",
author = "Gan, {G. G.} and {Chooi Fun}, Leong and Sangkar, {J. V.} and A. Teh and Goh, {K. Y.} and Cheong, {S. K.}",
year = "2005",
language = "English",
volume = "60",
pages = "311--313",
journal = "Medical Journal of Malaysia",
issn = "0300-5283",
publisher = "Malaysian Medical Association",
number = "3",

}

TY - JOUR

T1 - The use of mycophenolate mofetil in treating patients with non responding aplastic anemia

AU - Gan, G. G.

AU - Chooi Fun, Leong

AU - Sangkar, J. V.

AU - Teh, A.

AU - Goh, K. Y.

AU - Cheong, S. K.

PY - 2005

Y1 - 2005

N2 - Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for graft versus host disease in haemtopoeitic stem cell transplantation. It is thought that mycophenolate mofetil may be useful in this groups of patients. In this short report, mycophenolate mofetil was tried in 6 patients who had severe aplastic anemia with variable doses for a minimum duration of 9 months. The result has however not been encouraging.

AB - Aplastic anemia is a relatively uncommon disease and conventional management options include immunosuppressive drugs and/or haematopoeitic stem cell transplantation. It is now known that the pathogenesis of aplastic anemia is immune mediated. Mycophenolate mofetil is a common immunosuppressive drug now used mainly in prophylaxis of graft rejection in organ transplant and also for prevention/treatment for graft versus host disease in haemtopoeitic stem cell transplantation. It is thought that mycophenolate mofetil may be useful in this groups of patients. In this short report, mycophenolate mofetil was tried in 6 patients who had severe aplastic anemia with variable doses for a minimum duration of 9 months. The result has however not been encouraging.

KW - Aplastic anemia

KW - Immunosuppressive

KW - Mycophenolate mofetil

UR - http://www.scopus.com/inward/record.url?scp=33644803763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644803763&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 311

EP - 313

JO - Medical Journal of Malaysia

JF - Medical Journal of Malaysia

SN - 0300-5283

IS - 3

ER -